Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Quantification of serum hepatitis B surface antigen: is it useful for the management of chronic hepatitis B?

× No keyword cloud information.

27 in total

Review 1. How to achieve immune control in chronic hepatitis B?

Authors: Margo J H van Campenhout; Harry L A Janssen
Journal: Hepatol Int Date: 2014-09-06 Impact factor: 6.047

2. Sequential combination therapy with pegylated interferon leads to loss of hepatitis B surface antigen and hepatitis B e antigen (HBeAg) seroconversion in HBeAg-positive chronic hepatitis B patients receiving long-term entecavir treatment.

Authors: Guo-Jun Li; Yi-Qi Yu; Shao-Long Chen; Ping Fan; Ling-Yun Shao; Jia-Zhen Chen; Chang-Shui Li; Bin Yi; Wei-Cun Chen; Shu-Yuan Xie; Xiao-Na Mao; He-Hui Zou; Wen-Hong Zhang
Journal: Antimicrob Agents Chemother Date: 2015-05-04 Impact factor: 5.191

Review 3. [Which treatment options are validated for chronic viral hepatitis?].

Authors: C Höner zu Siederdissen; M P Manns; M Cornberg
Journal: Internist (Berl) Date: 2013-12 Impact factor: 0.743

4. The role of quantitative HBsAg in patients with HBV DNA between 2000-20,000 IU/ml.

Authors: Sibel Yıldız Kaya; Bilgül Mete; Abdurrahman Kaya; Ilker Inanç Balkan; Neşe Saltoglu; Ömer Fehmi Tabak
Journal: Wien Klin Wochenschr Date: 2021-04-29 Impact factor: 1.704

Review 5. Detectability and clinical significance of serum hepatitis B virus ribonucleic acid.

Authors: Yi-Wen Huang; Kazuaki Chayama; Jia-Horng Kao; Sien-Sing Yang
Journal: Hepatobiliary Surg Nutr Date: 2015-06 Impact factor: 7.293

6. Evaluation of changes of serum hepatitis B surface antigen from a different perspective.

Authors: Ze-Qian Wu; Lei Tan; Ting Liu; Zhi-Liang Gao; Wei-Min Ke
Journal: World J Gastroenterol Date: 2015-03-07 Impact factor: 5.742

7. Total Hepatitis B Core Antigen Antibody, a Quantitative Non-Invasive Marker of Hepatitis B Virus Induced Liver Disease.

Authors: Quan Yuan; Liu-Wei Song; Daniela Cavallone; Francesco Moriconi; Beatrice Cherubini; Piero Colombatto; Filippo Oliveri; Barbara Agata Coco; Gabriele Ricco; Ferruccio Bonino; James Wai Kuo Shih; Ning-Shao Xia; Maurizia Rossana Brunetto
Journal: PLoS One Date: 2015-06-26 Impact factor: 3.240

Review 8. Clinical utility of quantitative HBsAg in natural history and nucleos(t)ide analogue treatment of chronic hepatitis B: new trick of old dog.

Authors: Tai-Chung Tseng; Jia-Horng Kao
Journal: J Gastroenterol Date: 2012-10-24 Impact factor: 7.527

9. Close monitoring of hepatitis B surface antigen levels helps classify flares during peginterferon therapy and predicts treatment response.

Authors: Milan J Sonneveld; Roeland Zoutendijk; Hajo J Flink; Louwerens Zwang; Bettina E Hansen; Harry L A Janssen
Journal: Clin Infect Dis Date: 2012-10-05 Impact factor: 9.079

10. Lack of infectivity of HBV in feces from patients with chronic hepatitis B virus infection, and infection using chimeric mice.

Authors: Haruki Komatsu; Ayano Inui; Takeyoshi Murano; Tomoyuki Tsunoda; Tsuyoshi Sogo; Tomoo Fujisawa
Journal: BMC Res Notes Date: 2015-08-20

Quantification of serum hepatitis B surface antigen: is it useful for the management of chronic hepatitis B?